Hilary Boucher

Title: Hilary Boucher: Innovator in Drug Release Technology

Introduction

Hilary Boucher is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of drug delivery systems, particularly through her innovative work on controlling drug release in cross-linked poly(valerolactone) based matrices. Her research has the potential to enhance the effectiveness of pharmaceutical treatments.

Latest Patents

Hilary Boucher holds a patent titled "Factors controlling drug release in cross-linked poly(valerolactone) based matrices." This patent focuses on the development of a copolymer that includes poly(valerolactone), poly(allylvalerolactone), and polyethylene glycol (PEG). The invention describes a method for polymerizing these components and crosslinking them to create a matrix that can effectively load and release drugs. The patent emphasizes the importance of controlling the drug release profile, which can lead to improved therapeutic outcomes.

Career Highlights

Throughout her career, Hilary has worked with prominent organizations such as Pendant Biosciences, Inc. and the University of Toronto. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in drug delivery systems.

Collaborations

Hilary has collaborated with notable colleagues, including Timothy Tordella Ruckh and Carl Eric Elmquist. These partnerships have enriched her research and expanded the impact of her innovations in the pharmaceutical industry.

Conclusion

Hilary Boucher is a pioneering inventor whose work in drug release technology is shaping the future of pharmaceutical treatments. Her contributions are vital for advancing drug delivery systems and improving patient care.